The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
Angiogenesis and Inflammation Crosstalk in Diabetic Retinopathy
Abstract
Diabetic retinopathy (DR) is one of the most prevalent microvascular complications of diabetes and one of the most frequent causes of blindness in active age. Etiopathogenesis behind this important complication is related to several biochemical, hemodynamic and endocrine mechanisms with a preponderant initial role assumed by polyol pathways, increment of growth factors, accumulation of advanced glycation end products (AGE), activation of protein kinase C (PKC), activation of the renin‐angiotensin‐aldosterone system (RAAS), and leukostasis. Chronic and sustained hyperglycemia works as a trigger to the early alterations that culminate in vascular dysfunction. Hypoxia also plays an essential role in disease progression with promotion of neovascularization and vascular dystrophies with vitreous hemorrhages induction. Thus, the accumulation of fluids and protein exudates in ocular cavities leads to an opacity augmentation of the cornea that associated to neurodegeneration results in vision loss, being this a devastating characteristic of the disease final stage. During disease progression, inflammatory molecules are produced and angiogenesis occur. Furthermore, VEGF is overexpressed by the maintained hyperglycemic environment and up‐regulated by tissue hypoxia. Also pro‐inflammatory mediators regulated by cytokines, such as tumor necrosis factor (TNF‐α) and interleukin‐1 beta (IL‐1β), and growth factors leads to the progression of these processes, culminating in vasopermeability (diabetes macular edema) and/or pathological angiogenesis (proliferative diabetic retinopathy). It was found a mutual contribution between inflammation and angiogenesis along the process. J. Cell. Biochem. 117: 2443–2453, 2016. © 2016 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Global estimates of the prevalence of diabetes for 2010 and 2030
Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.007 · Cited by 7,216
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,311
Molecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
Global estimates of diabetes prevalence for 2013 and projections for 2035
Guariguata, L., Whiting, D. R., Hambleton, I., Beagley, J., Linnenkamp, U., & Shaw, J. E. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.002 · Cited by 4,642
Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412013312203 · Cited by 3,793
Wilkinson, C. P., Ferris, F. L., Klein, R. E., Lee, P. P., Agardh, C. D., Davis, M., Dills, D., Kampik, A., Pararajasegaram, R., & Verdaguer, J. T. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00475-5 · Cited by 3,743
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk
Hill, J. M., Zalos, G., Halcox, J. P. J., Schenke, W. H., Waclawiw, M. A., Quyyumi, A. A., & Finkel, T. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022287 · Cited by 3,423
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Endothelial Progenitor Cells: Characterization and Role in Vascular Biology
Urbich, C., & Dimmeler, S. (2004) · Circulation Research · doi:10.1161/01.res.0000137877.89448.78 · Cited by 2,369
Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury
Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006) · Circulation · doi:10.1161/circulationaha.106.621854 · Cited by 2,261
Matrix metalloproteinases as modulators of inflammation and innate immunity
Parks, W. C., Wilson, C. L., & López-Boado, Y. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1418 · Cited by 1,929
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
The Diabetic Retinopathy Clinical Research Network (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414264 · Cited by 1,607
Tepper, O. M., Galiano, R. D., Capla, J. M., Kalka, C., Gagne, P. J., Jacobowitz, G. R., Levine, J. P., & Gurtner, G. C. (2002) · Circulation · doi:10.1161/01.cir.0000039526.42991.93 · Cited by 1,448
The role of cyclooxygenases in inflammation, cancer, and development
Williams, C. S., Mann, M., & DuBois, R. N. (1999) · Oncogene · doi:10.1038/sj.onc.1203286 · Cited by 1,417
Protein kinase C activation and the development of diabetic complications.
Koya, D., & King, G. L. (1998) · Diabetes · doi:10.2337/diabetes.47.6.859 · Cited by 1,330
Mitchell, P., Bandello, F., Schmidt-Erfurth, U., Lang, G. E., Massin, P., Schlingemann, R. O., Sutter, F., Simader, C., Burian, G., Gerstner, O., et al. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.01.031 · Cited by 1,326
Inflammation in diabetic retinopathy
Tang, J., & Kern, T. S. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.05.002 · Cited by 1,116
Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting
Cade, W. T. (2008) · Physical Therapy · doi:10.2522/ptj.20080008 · Cited by 1,084
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
Wells, J. A., Glassman, A. R., Ayala, A. R., Jampol, L. M., Bressler, N. M., Bressler, S. B., Brucker, A. J., Ferris, F. L., Hampton, G. R., Jhaveri, C., et al. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.02.022 · Cited by 1,051
Resolution of in flammation: state of the art, definitions and terms
Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., & Wallace, J. L. (2007) · The FASEB Journal · doi:10.1096/fj.06-7227rev · Cited by 1,045
Pierce, E. A., Avery, R. L., Foley, E. D., Aiello, L. P., & Smith, L. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.905 · Cited by 1,027
IL-1 is required for tumor invasiveness and angiogenesis
Voronov, E., Shouval, D. S., Krelin, Y., Cagnano, E., Benharroch, D., Iwakura, Y., Dinarello, C. A., & Apte, R. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437939100 · Cited by 1,023
Ghasemi Falavarjani, K., & Nguyen, Q. D. (2013) · Eye · doi:10.1038/eye.2013.107 · Cited by 982
Management of Diabetic Retinopathy: A Systematic Review
Mohamed, Q., Gillies, M. C., & Wong, T. Y. (2007) · JAMA · doi:10.1001/jama.298.8.902 · Cited by 891
Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes
Klein, R. (1995) · Diabetes Care · doi:10.2337/diacare.18.2.258 · Cited by 845
Endothelial Progenitor Cell Dysfunction
Loomans, C. J. M., de Koning, E. J. P., Staal, F. J. T., Rookmaaker, M. B., Verseyden, C., de Boer, H. C., Verhaar, M. C., Braam, B., Rabelink, T. J., & van Zonneveld, A.-J. (2004) · Diabetes · doi:10.2337/diabetes.53.1.195 · Cited by 839
Diabetic Retinopathy and Diabetic Macular Edema
Ciulla, T. A., Amador, A. G., & Zinman, B. (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2653 · Cited by 836
Schmidt, A. M., Yan, S. D., Wautier, J.-L., & Stern, D. (1999) · Circulation Research · doi:10.1161/01.res.84.5.489 · Cited by 791
Oxidative Stress and Diabetic Retinopathy
Kowluru, R. A., & Chan, P.-S. (2007) · Journal of Diabetes Research · doi:10.1155/2007/43603 · Cited by 746
Gallagher, K. A., Liu, Z.-J., Xiao, M., Chen, H., Goldstein, L. J., Buerk, D. G., Nedeau, A., Thom, S. R., & Velazquez, O. C. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29710 · Cited by 667
Domingueti, C. P., Dusse, L. M. S., Carvalho, M. D. G., de Sousa, L. P., Gomes, K. B., & Fernandes, A. P. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.12.018 · Cited by 647
Goldberg, R. B. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2534 · Cited by 644
Fong, D. S., Aiello, L. P., Ferris, F. L., & Klein, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2540 · Cited by 640
Kern, T. S. (2007) · Journal of Diabetes Research · doi:10.1155/2007/95103 · Cited by 614
Diabetic Macular Edema: Pathogenesis and Treatment
Bhagat, N., Grigorian, R. A., Tutela, A., & Zarbin, M. A. (2009) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2008.10.001 · Cited by 571
Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppression
M. Joussen, A., Poulaki, V., Mitsiades, N., Kirchhof, B., Koizumi, K., Döhmen, S., & P. Adamis, A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0707fje · Cited by 567
Ben-Av, P., Crofford, L. J., Wilder, R. L., & Hla, T. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00956-a · Cited by 566
Metalloproteinases and their natural inhibitors in inflammation and immunity
Khokha, R., Murthy, A., & Weiss, A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3499 · Cited by 552
Ashton, N., Ward, B., & Serpell, G. (1954) · British Journal of Ophthalmology · doi:10.1136/bjo.38.7.397 · Cited by 494
Epidemiology of diabetic retinopathy and macular oedema: A systematic review
Williams, R., Airey, M., Baxter, H., Forrester, J., Kennedy-Martin, T., & Girach, A. (2004) · Eye · doi:10.1038/sj.eye.6701476 · Cited by 472
Endothelial Dysfunction in Diabetes
Avogaro, A., Albiero, M., Menegazzo, L., de Kreutzenberg, S., & Fadini, G. P. (2011) · Diabetes Care · doi:10.2337/dc11-s239 · Cited by 465
Pathophysiology of Diabetic Retinopathy
Tarr, J. M., Kaul, K., Chopra, M., Kohner, E. M., & Chibber, R. (2013) · ISRN Ophthalmology · doi:10.1155/2013/343560 · Cited by 455
Classification of diabetic retinopathy and diabetic macular edema
Wu, L. (2013) · World Journal of Diabetes · doi:10.4239/wjd.v4.i6.290 · Cited by 439
Diabetic Retinopathy: Vascular and Inflammatory Disease
Semeraro, F., Cancarini, A., dell’Omo, R., Rezzola, S., Romano, M. R., & Costagliola, C. (2015) · Journal of Diabetes Research · doi:10.1155/2015/582060 · Cited by 424
Ishida, S., Usui, T., Yamashiro, K., Kaji, Y., Amano, S., Ogura, Y., Hida, T., Oguchi, Y., Ambati, J., Miller, J. W., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022027 · Cited by 421
McLeod, D. S., Lefer, D. J., Merges, C., & Lutty, G. A. (1995) · PubMed Central · Cited by 418
Romeo, G., Liu, W.-H., Asnaghi, V., Kern, T. S., & Lorenzi, M. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2241 · Cited by 412
Concise Review: Circulating Endothelial Progenitor Cells for Vascular Medicine
Asahara, T., Kawamoto, A., & Masuda, H. (2011) · Stem Cells · doi:10.1002/stem.745 · Cited by 411
Müller Cell-Derived VEGF Is Essential for Diabetes-Induced Retinal Inflammation and Vascular Leakage
Wang, J., Xu, X., Elliott, M. H., Zhu, M., & Le, Y.-Z. (2010) · Diabetes · doi:10.2337/db09-1420 · Cited by 396
Demircan, N., Safran, B. G., Soylu, M., Ozcan, A. A., & Sizmaz, S. (2006) · Eye · doi:10.1038/sj.eye.6702138 · Cited by 395
VEGF164Is Proinflammatory in the Diabetic Retina
Ishida, S., Usui, T., Yamashiro, K., Kaji, Y., Ahmed, E., Carrasquillo, K. G., Amano, S., Hida, T., Oguchi, Y., & Adamis, A. P. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0807 · Cited by 383
Funatsu, H., Yamashita, H., Ikeda, T., Mimura, T., Eguchi, S., & Hori, S. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00568-2 · Cited by 346
The pathogenesis of diabetic retinopathy: old concepts and new questions
Cai, J., & Boulton, M. (2002) · Eye · doi:10.1038/sj.eye.6700133 · Cited by 344
Is diabetic retinopathy an inflammatory disease?
Adamis, A. P. (2002) · British Journal of Ophthalmology · doi:10.1136/bjo.86.4.363 · Cited by 341
Giebel, S. J., Menicucci, G., McGuire, P. G., & Das, A. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700251 · Cited by 325
Busik, J. V., Mohr, S., & Grant, M. B. (2008) · Diabetes · doi:10.2337/db07-1520 · Cited by 312
Doganay, S., Evereklioglu, C., Er, H., Türköz, Y., Sevinç, A., Mehmet, N., & Şavli, H. (2002) · Eye · doi:10.1038/sj.eye.6700095 · Cited by 294
Serum Inflammatory Markers in Diabetic Retinopathy
Meleth, A. D., Agro´n, E., Chan, C.-C., Reed, G. F., Arora, K., Byrnes, G., Csaky, K. G., Ferris, F. L., & Chew, E. Y. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1057 · Cited by 283
Cunha-Vaz, J. G. (1976) · Documenta Ophthalmologica · doi:10.1007/bf00146764 · Cited by 281
Tsutsumi, C., Sonoda, K.-H., Egashira, K., Qiao, H., Hisatomi, T., Nakao, S., Ishibashi, M., Charo, I. F., Sakamoto, T., Murata, T., et al. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0902436 · Cited by 277
OZAKI, H., HAYASHI, H., VINORES, S. A., MOROMIZATO, Y., CAMPOCHIARO, P. A., & OSHIMA, K. (1997) · Experimental Eye Research · doi:10.1006/exer.1996.0239 · Cited by 260
Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia–reperfusion injury in rats
Fadini, G. P., Sartore, S., Schiavon, M., Albiero, M., Baesso, I., Cabrelle, A., Agostini, C., & Avogaro, A. (2006) · Diabetologia · doi:10.1007/s00125-006-0401-6 · Cited by 255
Rangasamy, S., McGuire, P. G., Franco Nitta, C., Monickaraj, F., Oruganti, S. R., & Das, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108508 · Cited by 243
Vascular endothelial growth factor and diabetic complications
WIROSTKO, B., WONG, T., & SIMO, R. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.09.002 · Cited by 241
Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis
Dor, Y., Porat, R., & Keshet, E. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.6.c1367 · Cited by 237
Effects of Diabetes on the Eye
Lutty, G. A. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-12979 · Cited by 233
Diabetic retinopathy and inflammation: Novel therapeutic targets
Das, A., Rangasamy, S., & McGuire, P. (2012) · Middle East African Journal of Ophthalmology · doi:10.4103/0974-9233.92116 · Cited by 228
The role of advanced glycation in the pathogenesis of diabetic retinopathy
Stitt, A. W. (2003) · Experimental and Molecular Pathology · doi:10.1016/s0014-4800(03)00035-2 · Cited by 226
Omri, S., Behar-Cohen, F., de Kozak, Y., Sennlaub, F., Mafra Verissimo, L., Jonet, L., Savoldelli, M., Omri, B., & Crisanti, P. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.04.018 · Cited by 213
Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy
Zhang, S. X., & Ma, J.-X. (2007) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.09.002 · Cited by 208
Cheng, T., Cao, W., Wen, R., Steinberg, R. H., & LaVail, M. M. (1998) · PubMed · Cited by 203
Zong, H., Ward, M., Madden, A., Yong, P. H., Limb, G. A., Curtis, T. M., & Stitt, A. W. (2010) · Diabetologia · doi:10.1007/s00125-010-1900-z · Cited by 201
The RAGE Axis in Early Diabetic Retinopathy
Barile, G. R., Pachydaki, S. I., Tari, S. R., Lee, S. E., Donmoyer, C. M., Ma, W., Rong, L. L., Buciarelli, L. G., Wendt, T., Ho¨rig, H., et al. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1409 · Cited by 200
The Role of Microglia in Diabetic Retinopathy
Grigsby, J. G., Cardona, S. M., Pouw, C. E., Muniz, A., Mendiola, A. S., Tsin, A. T. C., Allen, D. M., & Cardona, A. E. (2014) · Journal of Ophthalmology · doi:10.1155/2014/705783 · Cited by 196
Anti-vascular endothelial growth factor therapy for diabetic macular edema
Boyer, D. S., Hopkins, J. J., Sorof, J., & Ehrlich, J. S. (2013) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018813512360 · Cited by 193
MURUGESWARI, P., SHUKLA, D., RAJENDRAN, A., KIM, R., NAMPERUMALSAMY, P., & MUTHUKKARUPPAN, V. (2008) · Retina · doi:10.1097/iae.0b013e31816576d5 · Cited by 189
Immune mechanisms in inflammatory and degenerative eye disease
Perez, V. L., & Caspi, R. R. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.04.003 · Cited by 188
Targeting inflammation in diabetes: Newer therapeutic options
Agrawal, N. K. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i5.697 · Cited by 186
Supplemental Oxygen Improves Diabetic Macular Edema: A Pilot Study
Nguyen, Q. D., Shah, S. M., Van Anden, E., Sung, J. U., Vitale, S., & Campochiaro, P. A. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-0557 · Cited by 178
Rangasamy, S., Srinivasan, R., Maestas, J., McGuire, P. G., & Das, A. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6386 · Cited by 177
Salicylate-Based Anti-Inflammatory Drugs Inhibit the Early Lesion of Diabetic Retinopathy
Zheng, L., Howell, S. J., Hatala, D. A., Huang, K., & Kern, T. S. (2007) · Diabetes · doi:10.2337/db06-0789 · Cited by 176
Mediators of ocular angiogenesis
Qazi, Y., Maddula, S., & Ambati, B. K. (2009) · Journal of Genetics · doi:10.1007/s12041-009-0068-0 · Cited by 170
Du, Y., Sarthy, V. P., & Kern, T. S. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00080.2003 · Cited by 169
Limb, G. A., Chignell, A. H., Green, W., LeRoy, F., & Dumonde, D. C. (1996) · British Journal of Ophthalmology · doi:10.1136/bjo.80.2.168 · Cited by 166
Role of Interleukin-1β in the Development of Retinopathy in Rats: Effect of Antioxidants
Kowluru, R. A., & Odenbach, S. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0633 · Cited by 164
Cyclooxygenase-2 in Human and Experimental Ischemic Proliferative Retinopathy
Sennlaub, F., Valamanesh, F., Vazquez-Tello, A., El-Asrar, A. M., Checchin, D., Brault, S., Gobeil, F., Beauchamp, M. H., Mwaikambo, B., Courtois, Y., et al. (2003) · Circulation · doi:10.1161/01.cir.0000080735.93327.00 · Cited by 161
Ayalasomayajula, S. P., & Kompella, U. B. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02793-0 · Cited by 152
Sibal, L., Aldibbiat, A. M., Agarwal, S., Mitchell, G., Oates, C. P., Razvi, S., Weaver, J. U., Shaw, J. A. M., & Home, P. (2009) · Diabetologia · doi:10.1007/s00125-009-1401-0 · Cited by 151
Zhang, J., Gerhardinger, C., & Lorenzi, M. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3499 · Cited by 149
Targeted Disruption of the CD18 or ICAM-1 Gene Inhibits Choroidal Neovascularization
Sakurai, E., Taguchi, H., Anand, A., Ambati, B. K., Gragoudas, E. S., Miller, J. W., Adamis, A. P., & Ambati, J. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-1246 · Cited by 135
Folkman, J., & Ingber, D. E. (1992) · PubMed · Cited by 135
Egan, C. G., Lavery, R., Caporali, F., Fondelli, C., Pasini, F. L., Dotta, F., & Sorrentino, V. (2008) · Diabetologia · doi:10.1007/s00125-008-0939-6 · Cited by 131
Role of inflammation in the pathogenesis of diabetic retinopathy
El‐Asrar, A. M. A. (2012) · Middle East African Journal of Ophthalmology · doi:10.4103/0974-9233.92118 · Cited by 128
Osteopontin (Eta-1) and Fibroblast Growth Factor-2 Cross-Talk in Angiogenesis
Leali, D., Dell’Era, P., Stabile, H., Sennino, B., Chambers, A. F., Naldini, A., Sozzani, S., Nico, B., Ribatti, D., & Presta, M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.1085 · Cited by 126
Funk, M., Schmidinger, G., Maár, N., Bolz, M., Benesch, T., Zlabinger, G. J., & Schmidt-Erfurth, U. M. (2010) · Retina · doi:10.1097/iae.0b013e3181e095c0 · Cited by 124
Early photocoagulation in patients with either type I or type II diabetes
Ferris, F. L. (1997) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70200-4 · Cited by 117
TNF-Alpha Levels in Tears: A Novel Biomarker to Assess the Degree of Diabetic Retinopathy
Costagliola, C., Romano, V., Tollis, M. D., Aceto, F., dell’Omo, R., Romano, M. R., Pedicino, C., & Semeraro, F. (2013) · Mediators of Inflammation · doi:10.1155/2013/629529 · Cited by 115
Maier, R., Weger, M., Haller–Schober, E.-M., El‐Shabrawi, Y., Wedrich, A., Theisl, A., Aigner, R., Barth, A., & Haas, A. (2008) · PubMed Central · Cited by 114
Leukocyte Adhesion Molecules in Diabetic Retinopathy
Noda, K., Nakao, S., Ishida, S., & Ishibashi, T. (2011) · Journal of Ophthalmology · doi:10.1155/2012/279037 · Cited by 113
Quantitative assessment of the integrity of the blood-retinal barrier in mice.
Derevjanik, N. L., Vinores, S. A., Xiao, W., Mori, K., Turon, T., Hudish, T. M., Dong, S., & Campochiaro, P. A. (2002) · PubMed · Cited by 112
Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema
Heier, J. S., Bressler, N. M., Avery, R. L., Bakri, S. J., Boyer, D. S., Brown, D. M., Dugel, P. U., Freund, K. B., Glassman, A. R., Kim, J. E., et al. (2015) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2015.4110 · Cited by 110
Brucklacher, R. M., Patel, K. M., VanGuilder, H. D., Bixler, G. V., Barber, A. J., Antonetti, D. A., Lin, C., LaNoue, K. F., Gardner, T. W., Bronson, S. K., et al. (2008) · BMC Medical Genomics · doi:10.1186/1755-8794-1-26 · Cited by 110
Angiopoietin concentrations in diabetic retinopathy
Patel, J. I. (2005) · British Journal of Ophthalmology · doi:10.1136/bjo.2004.049940 · Cited by 109
DIABETIC RETINOPATHY: EARLY FUNCTIONAL CHANGES
Alder, V. A., Su, E., Yu, D., Cringle, S. J., & Yu, P. K. (1997) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1997.tb02133.x · Cited by 103
Inflammation and Pharmacological Treatment in Diabetic Retinopathy
Kaštelan, S., Tomić, M., Antunica, A. G., Rabatić, J. S., & Ljubić, S. (2013) · Mediators of Inflammation · doi:10.1155/2013/213130 · Cited by 100
MATRIX METALLOPROTEINASES IN HUMAN DIABETIC AND NONDIABETIC VITREOUS
Jin, M., Kashiwagi, K., IIZUKA, Y., Tanaka, Y., Imai, M., & Tsukahara, S. (2001) · Retina · doi:10.1097/00006982-200102000-00005 · Cited by 100
Cutting Edge: IL-1β Mediates the Proangiogenic Activity of Osteopontin-Activated Human Monocytes
Naldini, A., Leali, D., Pucci, A., Morena, E., Carraro, F., Nico, B., Ribatti, D., & Presta, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4267 · Cited by 96
Microvascular complications and diabetic retinopathy: recent advances and future implications
Barot, M., Gokulgandhi, M. R., Patel, S., & Mitra, A. K. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.12.206 · Cited by 92
Bursell, S. E., Takagi, C., Clermont, A., Takagi, H., Mori, F., Ishii, H., & King, G. L. (1997) · PubMed · Cited by 91
Genetics in Diabetic Retinopathy: Current Concepts and New Insights
Simó‐Servat, O., Hernández, C., & Simó, R. (2013) · Current Genomics · doi:10.2174/13892029113149990008 · Cited by 89
Resveratrol and the eye: activity and molecular mechanisms
Bola, C., Bartlett, H. E., & Eperjesi, F. (2014) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-014-2604-8 · Cited by 89
The role of oxidative stress in diabetic retinopathy
Gürler, B., Vural, H., Yılmaz, N., Oğuz, H., Satici, A., & Aksoy, N. (2000) · Eye · doi:10.1038/eye.2000.193 · Cited by 88
Metabolic memory and diabetic retinopathy: Role of inflammatory mediators in retinal pericytes
Kowluru, R. A., Zhong, Q. P. W., & Kanwar, M. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.02.006 · Cited by 88
Li, G., Veenstra, A. A., Talahalli, R. R., Wang, X., Gubitosi‐Klug, R., Sheibani, N., & Kern, T. S. (2012) · Diabetes · doi:10.2337/db11-1249 · Cited by 87
Anti-VEGF Therapy for Diabetic Macular Edema
Stewart, M. W. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0510-4 · Cited by 86
Gologorsky, D., Thanos, A., & Vavvas, D. G. (2012) · Mediators of Inflammation · doi:10.1155/2012/629452 · Cited by 84
Uckermann, O., Kutzera, F., Wolf, A., Pannicke, T., Reichenbach, A., Wiedemann, P., Wolf, S., & Bringmann, A. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.092353 · Cited by 82
Natural product inhibitors of ocular angiogenesis
Sulaiman, R. S., Basavarajappa, H. D., & Corson, T. W. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.10.002 · Cited by 80
Zijlstra, A., Seandel, M., Kupriyanova, T. A., Partridge, J. J., Madsen, M. A., Hahn-Dantona, E. A., Quigley, J. P., & Deryugina, E. I. (2005) · Blood · doi:10.1182/blood-2005-04-1458 · Cited by 76
Capeáns, C., ROJAS, V. M. D., LOJO, S., & SALORIO, M. S. (1998) · Retina · doi:10.1097/00006982-199806000-00009 · Cited by 75
Expression of aquaporin-1 immunoreactivity by photoreceptor cells in the mouse retina
Iandiev, I., Pannicke, T., Reichel, M. B., Wiedemann, P., Reichenbach, A., & Bringmann, A. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.06.046 · Cited by 70
Vitreous Mediators in Retinal Hypoxic Diseases
dell’Omo, R., Semeraro, F., Bamonte, G., Cifariello, F., Romano, M. R., & Costagliola, C. (2013) · Mediators of Inflammation · doi:10.1155/2013/935301 · Cited by 65
New Diagnostic and Therapeutic Approaches for Preventing the Progression of Diabetic Retinopathy
Park, Y. G., & Roh, Y. (2015) · Journal of Diabetes Research · doi:10.1155/2016/1753584 · Cited by 62
Sasongko, M. B., Wong, T. Y., Jenkins, A. J., Nguyen, T. T. L., Shaw, J. E., & Wang, J. J. (2014) · Diabetic Medicine · doi:10.1111/dme.12640 · Cited by 61
Costagliola, C. (1990) · PubMed · Cited by 61
Laser Treatment in Diabetic Retinopathy
Neubauer, A. S., & ULBIG, M. W. (2007) · Ophthalmologica · doi:10.1159/000098254 · Cited by 59
Brown, J. B., Pedula, K. L., & Summers, K. H. (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2637 · Cited by 56
Caspase-Dependent Apoptosis of Retinal Ganglion Cells During the Development of Diabetic Retinopathy
Adamiec-Mroczek, J., Zając-Pytrus, H. M., & Misiuk‐Hojło, M. (2015) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/31805 · Cited by 56
Targeting Leukostasis for the Treatment of Early Diabetic Retinopathy
Patel, N. (2009) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/187152909789007052 · Cited by 52
Ling, R., Ramsewak, V., Taylor, D., & Jacob, J. (2002) · Eye · doi:10.1038/sj/eye/6700081 · Cited by 52
Diabetes impairs mobilization of stem cells for the treatment of cardiovascular disease
Fadini, G. P., & Avogaro, A. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.10.089 · Cited by 50
Current Approaches to the Management of Diabetic Retinopathy and Diabetic Macular Oedema
Boscia, F. (2010) · Drugs · doi:10.2165/11538130-000000000-00000 · Cited by 46
Semeraro, F., Cancarini, A., Morescalchi, F., Romano, M. R., dell’Omo, R., Ruggeri, G., Agnifili, L., & Costagliola, C. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.04.005 · Cited by 44
Costagliola, C., Daniele, A., dell’Omo, R., Romano, M. R., Aceto, F., Agnifili, L., Semeraro, F., & Porcellini, A. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2013.02.004 · Cited by 39
Stewart, M. W. (2012) · Current Diabetes Reviews · doi:10.2174/157339912800840488 · Cited by 38
Recent developments in laser treatment of diabetic retinopathy
Yun, S., & Adelman, R. A. (2015) · Middle East African Journal of Ophthalmology · doi:10.4103/0974-9233.150633 · Cited by 38
Chibber, R., Pa, M., & KOHNER, E. M. (1999) · PubMed · Cited by 38
Henriques, J., Vaz-Pereira, S., Nascimento, J., & Rosa, P. C. (2015) · Acta Médica Portuguesa · doi:10.20344/amp.5361 · Cited by 33
Synthesis and Mechanistic Studies of a Novel Homoisoflavanone Inhibitor of Endothelial Cell Growth
Basavarajappa, H. D., Lee, B., Fei, X., Lim, D., Callaghan, B., Mund, J. A., Case, J., Gangaraju, R., Seo, S., & Corson, T. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095694 · Cited by 33
Plasma Kallikrein and Diabetic Macular Edema
Feener, E. P. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0127-1 · Cited by 32
Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?
Ortiz, G., Salica, J. P., Chuluyán, E., & Gallo, J. E. (2014) · Biological Research · doi:10.1186/0717-6287-47-58 · Cited by 31
Cited by
Impact of Metabolic Syndrome on Neuroinflammation and the Blood–Brain Barrier
Van Dyken, P., & Lacoste, B. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00930 · Cited by 359
Oxidative Stress: Signaling Pathways, Biological Functions, and Disease
Liu, S., Liu, J., Wang, Y., Deng, F., & Deng, Z. (2025) · MedComm · doi:10.1002/mco2.70268 · Cited by 359
Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy
Xu, J., Chen, L.-J., Yu, J., Wang, H.-J., Zhang, F., Liu, Q., & Wu, J. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000491897 · Cited by 204
Antioxidant Phytochemicals as Potential Therapy for Diabetic Complications
Akpoveso, O.-O. P., Ubah, E. E., & Obasanmi, G. (2023) · Antioxidants · doi:10.3390/antiox12010123 · Cited by 90
Effects of Coconut Water on Retina in Diabetic Rats
Zhang, X., Peng, L., Dai, Y., Sheng, X., Chen, S., & Xie, Q. (2020) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2020/9450634 · Cited by 14
Metadata
- Authors
- Capitão, M., & Soares, R.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2016-07-21
- Volume
- 117
- Issue
- 11
- Pages
- 2443-2453
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W2385884905
- Cited by
- 312
- References
- 142
- FWCI
- 21.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.